OMBIO D

OMBIO D is a specialized formulation created to target complex gastrointestinal conditions, with a particular focus on managing Gastroesophageal Reflux Disease (GERD) that does not adequately respond to standard acid-suppressing treatments. This product employs a dual-action approach that significantly curtails the production of stomach acid while facilitating the effective passage of food through the digestive system, thereby diminishing discomfort and enhancing digestive performance. The formulation includes two active components: Omeprazole and Domperidone. Omeprazole, a Proton Pump Inhibitor at a dosage of 20mg, works by irreversibly blocking the proton pump in the stomach lining, which is crucial for acid secretion. This results in a marked decrease in stomach acidity, providing long-lasting relief from symptoms such as heartburn and acid regurgitation, and aids in the healing of esophageal tissue damaged by acid exposure. Domperidone, at a dosage of 10mg, acts as a prokinetic agent and antiemetic, enhancing motility in the upper gastrointestinal tract and preventing nausea and vomiting. By improving gastric emptying, Domperidone prevents acid and food from remaining in the stomach for extended periods, which is essential in managing symptoms associated with GERD. Together, these components create a synergistic effect that addresses both acid production and digestive motility, offering comprehensive symptom relief for patients grappling with GERD and associated complications.